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ARTICLE
Plekhg5-regulated autophagy of synaptic vesicles
reveals a pathogenic mechanism in motoneuron
disease
Patrick Lüningschrör1,2, Beyenech Binotti3, Benjamin Dombert1, Peter Heimann2, Angel Perez-Lara 3,
Carsten Slotta2, Nadine Thau-Habermann4, Cora R. von Collenberg1, Franziska Karl5, Markus Damme6,
Arie Horowitz 7, Isabelle Maystadt8, Annette Füchtbauer9, Ernst-Martin Füchtbauer9, Sibylle Jablonka1,
Robert Blum1, Nurcan Üçeyler5, Susanne Petri4,10, Barbara Kaltschmidt2,11, Reinhard Jahn3,
Christian Kaltschmidt2 & Michael Sendtner 1
Autophagy-mediated degradation of synaptic components maintains synaptic homeostasis
but also constitutes a mechanism of neurodegeneration. It is unclear how autophagy of
synaptic vesicles and components of presynaptic active zones is regulated. Here, we show
that Pleckstrin homology containing family member 5 (Plekhg5) modulates autophagy of
synaptic vesicles in axon terminals of motoneurons via its function as a guanine exchange
factor for Rab26, a small GTPase that speciﬁcally directs synaptic vesicles to
preautophagosomal structures. Plekhg5 gene inactivation in mice results in a late-onset
motoneuron disease, characterized by degeneration of axon terminals. Plekhg5-depleted
cultured motoneurons show defective axon growth and impaired autophagy of synaptic
vesicles, which can be rescued by constitutively active Rab26. These ﬁndings deﬁne a
mechanism for regulating autophagy in neurons that speciﬁcally targets synaptic vesicles.
Disruption of this mechanism may contribute to the pathophysiology of several forms of
motoneuron disease.
DOI: 10.1038/s41467-017-00689-z OPEN
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In neurons, autophagosome biogenesis predominantly takesplaces in axon terminals. Newly synthesized autophagosomesmature during retrograde transport to the soma and fuse
with lysosomes1, 2. Autophagy-mediated degradation of synaptic
components is involved in neuronal network remodeling,
presynaptic neurotransmission and synaptic pruning at
polyinnervated neuromuscular junctions during development,
but could also represent a mechanism of neurodegeneration3–6.
Selective elimination of axon terminals marks disease onset in
familial amyotrophic lateral sclerosis (ALS) and loss of synaptic
vesicles precedes axon degeneration in SOD1 G93A mice7,
indicating that autophagy temporally regulates degradation of
synaptic vesicles in axon terminals. Neuron-speciﬁc disruption of
autophagy by depletion of Atg5 or Atg7 results in progressive
deﬁcits of motor function and neurodegeneration8, 9. Modulation
of the autophagy pathway modiﬁes disease onset and progression
in SOD1 G93A mice, which further points to the contribution
of autophagy to the pathology of motoneuron disease10, 11.
However, the molecular mechanisms that differentially regulate
autophagy of synaptic vesicles and components of presynaptic
active zones are not known.
Here, we show that Plekhg5 (also known as Syx, Tech or
GEF720)12–14 regulates autophagy of synaptic vesicles in moto-
neurons via its function as a guanine exchange factor (GEF) for
Rab26, a small GTPase selectively delivering synaptic vesicles into
preautophagosomes15. Plekhg5 is a pleckstrin homology domain
containing member of the GEF family. It is predominantly
expressed in the nervous system12, 14. While several studies
provided evidence for a function of Plekhg5 in endothelial
cell migration and angiogenesis in zebraﬁsh and mice13, 16, its
function in the nervous system remained elusive. Mutations in
the PLEKHG5 gene have been associated with different forms of
motoneuron diseases such as distal spinal muscular atrophy type
IV (DSMA-IV)17, intermediate Charcot-Marie-Tooth disease
(CMT)18, 19 and ALS20. The PLEKHG5-mutations identiﬁed so
far in CMT disease patients produce premature stop codons
and are predicted to result in a functional null allele18, 19. In
contrast, mutations described to be causative for a recessive lower
motoneuron disease with childhood onset lead to an exchange of
one amino acid within the pleckstrin homology domain17, 20.
To analyze the function of Plekhg5 in the nervous system and
its involvement in motoneuron disease, we generated Plekhg5-
deﬁcient mice using a gene-trap approach21. Plekhg5-deﬁcient
mice develop a late-onset motoneuron disease, characterized by
degeneration of motoneuron axon terminals. Plekhg5-depleted
cultured motoneurons show defective autophagy resulting in
accumulation of synaptic vesicles at axon terminals and impaired
axon growth. Furthermore, Plekhg5-deﬁcient cells show a
reduced activity of Rab26. In a cell-free system Plekhg5 is able to
promote GTP exchange of Rab26. Finally, constitutively active
Rab26 rescues autophagy and axon growth deﬁcits of cultured
motoneurons. Our data indicate that the function of Plekhg5 as a
GEF for Rab26 is essential for axonal integrity, and that defective
autophagy of synaptic vesicles is a pathogenic mechanism in this
speciﬁc form of motoneuron disease.
Results
Plekhg5 deﬁciency causes a late-onset motoneuron disease.
To analyze the cellular function of Plekhg5, we generated
Plekhg5-deﬁcient mice using an embryonic stem-cell line
harboring a gene-trap cassette within the Plekhg5 allele (Fig. 1),
(Supplementary Fig. 1)21. Plekhg5-deﬁcient mice developed
normally without obvious disease phenotype up to adulthood.
However, within 24 months after birth 33 out of 100 homozygous
mice died, in contrast to 10 out of 100 heterozygous and 5 out of
100 wild-type animals (Fig. 1a). Affected mice developed hind-
limb paralysis at 15 months (Fig. 1b). A reduction in body weight
became apparent in 18−24 months old Plekhg5-deﬁcient mice
(Fig. 1c). To assess the impact of Plekhg5 deﬁciency on motor
performance in more detail, grip strength (Fig. 1e, f) and rotarod
performance (Fig. 1g) were analyzed in animals of different ages.
These data indicate that the disease starts late at about 12 months
of age and progresses from hindlimbs (Fig. 1f) to forelimbs
(Fig. 1e). Correlating with reduced grip strength, we observed
a loss of motoneurons starting at 12 months as shown by
quantiﬁcation of Nissl-stained lumbar spinal cord sections
(Fig. 1d, h). This decrease was more prominent in 24-month-old
animals (Fig. 1d).
We complemented the phenotypic characterization of the
motor system with nerve conduction and electromyography
studies of the gastrocnemius and plantaris muscles (Fig. 1j–l, o).
In both muscles we observed a signiﬁcantly delayed motor
latency time (Fig. 1i). The measurements in the gastrocnemius
muscles also showed a marked reduction of motor unit
potential (MUP) amplitudes following sciatic nerve-stimulation
(Fig. 1j). Our analyses revealed elevated single motor unit
potentials (SMUP) (Fig. 1k) and a decrease in motor unit
number estimation (MUNE) (Fig. 1l) in the gastrocnemius
muscle, suggestive of sprouting of surviving motoneurons to
re-innervate muscle ﬁbers that have been denervated upon
motoneuron loss. This ﬁnding is also supported by the observed
ﬁber grouping as shown by succinate dehydrogenase (SDH)
staining (Fig. 1m). These data are similar to the observed
sprouting phenotype reported in SOD G93A mice22. As
previously described for Plekhg5 mutant mice19, we also
detected a modest decrease in nerve conduction velocities
(NCVs) (Fig. 1o).
Next, we investigated β-GEO reporter-activity of the gene-trap
cassette in mutant mice. In contrast to spinal cord,
β-galactosidase activity was not detected in skeletal muscle
(Fig. 1n). Therefore, loss of Plekhg5 apparently does not affect
the skeletal muscle directly, but rather indirectly via denervation
and motoneuron loss.
We also assessed the impact of Plekhg5 deﬁciency on sensory
and cognitive function. Sensory function was analyzed using the
von Frey and Hargreaves tests (Fig. 1p, q). Whereas Plekhg5-
deﬁcient mice did not show major changes in mechanical
withdrawal thresholds as compared to wild-type littermates
(Fig. 1p), they displayed hypersensitivity to heat (Fig. 1p),
indicating that sensory perception is not reduced in these mice.
To address whether Plekhg5 deﬁciency impairs cognitive
function, we performed behavioral tests in 12−14-month-old
mice (Supplementary Fig. 2), before motor disease symptoms
occur. Plekhg5-deﬁcient mice performed similarly in the
open ﬁeld test (Supplementary Fig. 2a, b) indicating that
anxiety-related behavior is not altered. They also did not display
differences in object recognition (Supplementary Fig. 2c, d)
and fear conditioning (Supplementary Fig. 2e, f) suggestive
for unaffected learning and memory.
Plekhg5 modulates synaptic vesicle turnover in motoneurons.
Next, we studied neuromuscular junctions (NMJs) within the
gastrocnemius muscle to analyze whether the degenerative
process in Plekhg5−/− mice involves terminal axons (Fig. 2a, c;
Supplementary Fig. 3). Wild-type animals exhibited regular
pretzel-like NMJs at an age of 12 months, as indicated by
bungarotoxin (BTX) staining for labeling of postsynaptic
acetylcholine-receptors and synaptophysin immunoreactivity
for the corresponding presynaptic compartment (Fig. 2a;
Supplementary Fig. 3). In contrast, the presynaptic nerve
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Fig. 1 Plekhg5-deﬁcient mice develop a motoneuron disease with late onset. a Survival analysis of Plekhg5 mutant mice. (Mean survival after 24 months:
Plekhg5+/+: 95%, n= 48; Plekhg5+/−: 89%, n= 112; Plekhg5−/−: 68%, n= 351; p= 0.0068; log-rank test) b Hind-limb clasping defects in 15-month-old
Plekhg5-deﬁcient mice. c Body weight measurements of Plekhg5-deﬁcient and control mice of different ages (2−4 months, Plekhg5+/+: n= 12, Plekhg5−/−:
n= 9; 9−15 months, Plekhg5+/+: n= 19, Plekhg5−/−: n= 42; 18−25 months, Plekhg5+/+: n= 18, Plekhg5−/−: n= 36; two-way ANOVA; Bonferroni
post-test). d Number of motoneurons was counted in lumbar spinal cord sections (3 months, n= 5; 12 months, n= 5; 24 months, n= 3; unpaired t-test;
two-tailed. e, f Grip strength measurements of fore- e and hindlimbs f. g Rotarod performance (9−15 months, Plekhg5+/+: n= 9, Plekhg5−/−: n= 10; 18
−24 months, Plekhg5+/+: n= 11, Plekhg5−/−: n= 8; two-way ANOVA; Bonferroni post-test). h Nissl-stained motoneurons in spinal sections from Plekhg5+/+
and Plekhg5−/− mice. Scale bar: 40 µm. i−l Electrophysiological recordings of gastrocnemius and plantaris muscles (Plekhg5+/+: n= 6, Plekhg5−/−: n= 6;
unpaired t-test; two-tailed). Latency i and amplitude j of muscle depolarization upon stimulation of the sciatic nerve. k, l Single motor unit potential (SMUP)
k and motor unit number estimation (MUNE) l of the gastrocnemius muscle. m Succinate dehydrogenase (SDH) staining of the gastrocnemius muscle.
Scale bar: 500 µm. n X-Gal staining of cross-sectioned spinal cord and gastrocnemius muscle. Scale bar: 20 µm. o Sciatic nerve conduction velocities
(Plekhg5+/+: n= 6, Plekhg5−/−: n= 6; unpaired t-test; two-tailed) p, q Box- and whisker-plots show mechanical withdrawal thresholds p and heat
withdrawal latencies (s) q of naive male Plekhg5−/− and control littermates. Mechanical withdrawal thresholds did not differ between genotypes p. Plekhg5
−/− mice showed heat hypersensitivity as compared to control littermates (Plekhg5+/+: n= 5, Plekhg5−/−: n= 5; Mann−Whitney U-test)
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terminals of Plekhg5−/− mice appeared swollen with accumula-
tions of synaptophysin (Fig. 2a, c; Supplementary Fig. 3) and
neuroﬁlament-H (NF-H) (Supplementary Fig. 3).
Respiratory failure due to progressive impairment of the
neuromuscular system has been reported as a main cause of
death in ALS and the major trigger for premature death in SOD1
G93A mice23. We therefore investigated whether NMJs within
intercostal muscles of Plekhg5-deﬁcient mice also show signs
of degeneration. We observed a phenotype similar as in the
gastrocnemius muscle with deformed and swollen axon terminals
(Fig. 2b, d), indicating that muscles necessary for respiration
become denervated which could make a major contribution to
premature death.
At the ultrastructural level, axon terminals of Plekhg5-deﬁcient
mice were ﬁlled with membrane fragments and cytoplasmic
inclusions (Fig. 3a–e), similar as those observed in patients with
ALS24, 25. Strikingly, synaptic vesicles in Plekhg5−/− motoneuron
terminals were frequently enlarged, in contrast to synaptic
vesicles in wild-type mice, which appeared smaller and of a
more uniform size (Fig. 3f–h). Furthermore, the organization of
actin ﬁlaments in axon terminals appeared altered, with more
actin ﬁbers in close neighborhood of synaptic vesicles in active
zones (Fig. 3f, g). In line with these ﬁndings we detected elevated
protein levels of several synaptic vesicle markers in sciatic nerve
lysates of Plekhg5−/− mice (Fig. 3i, j). The ultrastructural
examination of NMJs also revealed axonal swellings in distal
axons (Fig. 4a). Axons showed a highly disorganized cytoskeleton
(Fig. 4b, c). Axonal swellings were also frequently detectable in
spinal cord and sciatic nerve cross-sections (Fig. 4d–j). In
contrast, we detected no axonal swelling in wild-type animals
(Fig. 4j). Taken together, these data indicate that Plekhg5
deﬁciency results in degradation of axon terminals, but also
affects axonal integrity in proximal parts of axons.
Next, we studied the impact of Plekhg5 deﬁciency on synapse-
morphology in the central nervous system and stained brain
sections for synaptophysin and Tuj1 (Supplementary Fig. 4). The
overall morphology and layering of the hippocampus, cerebellum
and cortex appeared normal (Supplementary Fig. 4). In contrast
to the abnormally swollen appearance of motoneuron terminals
with synaptophysin-accumulations, synapses within the brain
appeared unaffected in Plekhg5-deﬁcient mice (Supplementary
Fig. 4). These observations are in line with our data on normal
cognitive function in Plekhg5-deﬁcient mice.
Plekhg5 regulates autophagy in motoneurons. Under
physiological conditions damaged organelles are removed
from axon terminals by autophagy1, 2, 6. To assess whether
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Fig. 2 Degradation of neuromuscular junctions in Plekhg5-deﬁcient mice. a, b NMJs within the gastrocnemius a and intercostal b muscles stained for
BTX and synaptophysin. Scale bar: 10 µm. c, d Quantiﬁcation of presynaptic area by evaluation of synaptophysin staining and measurement of the
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post-test)
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dysregulated autophagy causes the accumulation of synaptic
vesicles at nerve terminals we examined the autophagic ﬂux in
Plekhg5-deﬁcient motoneurons (Fig. 5). Since autophagosomes
rapidly fuse with lysosomes, changes in the biogenesis of autop-
hagosomes are hardly detectable under basal conditions26, 27.
Therefore, cultured motoneurons were transduced with lenti-
viruses expressing GFP-RFP-LC3 and treated with baﬁlomycin
A1 after 7 days in culture (Fig. 5a–c). Baﬁlomycin A1 blocks the
fusion of autophagosomes and lysosomes resulting in an
enrichment of LC3-II positive autophagosomes. Since fusion of
autophagosomes and lysosomes quenches the ﬂuorescence of
GFP, RFP positive structures selectively mark autolysosomes,
whereas autophagosomes appear positive for both RFP and
GFP27. Under basal conditions we detected no difference in the
number of autophagosomes and autolysosomes in the soma of
wild-type and Plekhg5−/− cells. However, upon treatment with
baﬁlomycin A1 Plekhg5-deﬁcient cells displayed a signiﬁcantly
reduced number of autophagosomes in comparison to wild-type
motoneuron somata (Fig. 5a, b). In axons of Plekhg5−/− moto-
neurons, a reduced number of autophagosomes was detected in
both untreated cells and baﬁlomycin A1 treated cells (Fig. 5a, c).
In agreement with previous reports we only identiﬁed very few
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j Quantiﬁcation of axonal swellings in spinal cord semi-thin cross-sections. Three animals per genotype were analyzed. Each data point represents the
mean of 10 sections from individual animals with a distance of 100 µm between each section
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autolysosomes in axons of cultured motoneurons, conﬁrming
that full maturation of autophagosomes to lysosomes
mostly occurs within or close to the soma1, 26. The number of
autolysosomes was not altered indicating that acidiﬁcation of
autolysosomes, as a late step of maturation, was unaffected
(Fig. 5a–c). To examine whether Plekhg5 deﬁciency causes
impaired axonal transport of autophagosomes, motoneurons
were transduced with RFP-GFP-LC3, and the movement of
GFP-LC3+ structures was analyzed (Fig. 5d–f). Plekhg5−/−
motoneurons showed a reduced number of autophagosomes
moving retrogradely towards the soma (Fig. 5f), whereas the
relative number of retrogradely moving autophagosomes
appeared unaltered (Fig. 5e; Supplementary Movie 1, 2). Reduced
protein levels of endogenous LC3-II were also biochemically
detected in Plekhg5-deﬁcient neurosphere-derived neurons upon
treatment with baﬁlomycin A1 by western blotting
(Fig. 5g, h). This reduction of LC3-II levels was also apparent in
spinal cord extracts of 24-month-old mice (Fig. 5i, j).
Taken together, these data emphasize that the biogenesis of
autophagosomes is impaired in Plekhg5-deﬁcient motoneurons
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resulting in a reduced number of retrogradely transported
autophagosomes. The remaining autophagosomes are trans-
ported normally.
An essential process for autophagosome formation is the
production of phosphatidylinositol 3-phosphate (PI(3)P) by
phosphatidylinositol-3-kinase class III at preautophagosomal mem-
branes28. Pleckstrin homology (PH) domains form a conserved
family that mediates protein association to inositol lipids like PI(3)
P. We analyzed whether Plekhg5 binds to PI(3)P using extracts
from mouse motoneuron-like hybrid cells (NSC34) expressing Flag-
tagged Plekhg5. We could precipitate Plekhg5 with PI(3)P-coated
beads but not with control beads (Fig. 5m) suggesting that Plekhg5
is able to associate with PI(3)P at preautophagosomal membranes28.
For monitoring the fate of Plekhg5 upon induction of autophagy,
Plekhg5-YFP transfected NSC34 cells were starved for 4 h in HBSS
and the expression of Plekhg5-YFP was analyzed by western blot
(Fig. 5k). In contrast to a marked reduction of full-length Plekhg5-
YFP, the signal for smaller protease-resistant YFP-positive
fragments increased (Fig. 5k). Nutrient deprivation differently
affects cell lines and primary neurons. Therefore, we also performed
this experiment with cultured motoneurons by replacing enriched
motoneuron-media with different media each deprived of speciﬁc
nutrient components (Fig. 5l). As observed in NSC34 cells, nutrient
deprivation resulted in degradation of Plekhg5. In contrast to
overexpressed Flag-Plekhg5, endogenous Plekhg5 appeared as
multiple bands that were differently affected by nutrient deprivation
(Fig. 5l). The identity of the bands that were detected by western
blot analysis was controlled by sh-RNA-mediated knockdown of
Plekhg5 (Fig. 5l; Supplementary Fig. 5a, b). In summary, these
experiments suggest that Plekhg5 is able to bind PI(3)P, placing
Plekhg5 to the inner autophagosomal membrane. This idea is
further supported by the degradation of Plekhg5 upon autophagy
induction. Fusion of autophagosomes with lysosomes results in
digestion of proteins in the lumen of the autophagosome including
proteins localized to the inner autophagosomal membrane29.
Next, we determined whether impaired autophagy affects
survival and/or morphology of Plekhg5-depleted motoneurons
in vitro. Plekhg5-depleted motoneurons grew shorter axons,
whereas cell survival and dendritic complexity was not affected
(Fig. 6a, b; Supplementary Fig. 5). In order to ﬁnd out how altered
autophagy leads to axonal growth defects, we characterized the
morphology of axon terminals in Plekhg5−/− motoneurons.
Growth cones of cultured Plekhg5−/− motoneurons appeared
atrophic with a signiﬁcantly smaller size and with dysmorphic
densely packed accumulation and clustering of synaptophysin-
positive synaptic vesicles leading to a reduced number of F-actin
ﬁlaments (Fig. 6c, d). We next looked at the expression pattern
of Rab26 in axons of cultured motoneurons. Rab26 is a
small GTPase enriched on synaptic vesicles designated for delivery
to preautophagosomal structures15. In its GTP-bound form Rab26
is an effector of Atg16L leading to recruitment of the autophagy
machinery to synaptic vesicles. In Plekhg5-deﬁcient cells Rab26-
positive structures accumulate in regions directly at active zones,
in contrast to wild-type motoneurons where these structures are
found in more proximal areas of axonal growth cones (Fig. 6c, d).
To examine these morphological alterations in more depth, we
performed SIM microscopy (Fig. 6e). These high-resolution
images conﬁrmed the data obtained by confocal microscopy
providing additional evidence that the number of Rab26-positive
vesicles increased, and the actin cytoskeleton disorganized
(Fig. 6e). These ﬁndings support the in vivo structural analyses
demonstrating marked alterations in cytoskeletal structures
(Fig. 4b, c), which might cause the defect in axon growth.
Plekhg5 functions as a GEF for Rab26. Activation of GTPases
requires dissociation of protein-bound GDP, an intrinsically slow
process that is accelerated by speciﬁc GEFs30. To explore whether
Plekhg5 regulates the activity of Rab26, neurosphere-derived
cortical neurons were transduced with EGFP-Rab26 and labeled
with 32P for 4 h. Subsequently, EGFP-Rab26 was immunopreci-
pitated and GTP- or GDP-bound Rab26 was separated by thin
layer chromatography (TLC) (Fig. 7a), revealing a signiﬁcantly
reduced GTP/GDP ratio (Fig. 7b). Next, we asked whether
Plekhg5 is able to directly act as a GEF for Rab26 in a cell-free
system (Fig. 7c–h). Using homogenously puriﬁed recombinant
proteins we analyzed the ability of Plekhg5 to catalyze GDP
dissociation of Rab26 and observed a marked acceleration of GTP
exchange in the presence of the DH-PH (Dbl-homologous-
Pleckstrin homology) tandem domain of Plekhg5 for Rab26
(Fig. 7g, h), but not for Rab5, Rab27b, or Rab33b
(Fig. 7d–f). These data demonstrate that Plekhg5 acts as a GEF for
Rab26.
We then followed this line of experiments and tested wild-type
and a constitutively active form of Rab26, Rab26Q123L (Rab26-
QL), in cultured motoneurons (Fig. 8). As previously described,
wild-type EGFP-Rab26 accumulated in vesicles within axons15. In
Plekhg5-deﬁcien motoneurons, the size of these vesicles was
signiﬁcantly reduced (Fig. 8a, c), and the number of EGFP-Rab26
vesicles was also modestly reduced (Fig. 8a, d). With constitutive
active EGFP-Rab26, the number and size of these vesicles
normalized and no differences between wild-type and Plekhg5-
deﬁcient cells were detectable (Fig. 8a, c, d). In correlation with
these ﬁndings, EGFP-Rab26-QL also fully restored axon growth
Fig. 5 Plekhg5 regulates biogenesis of autophagosomes. a Motoneurons of Plekhg5+/+ and Plekhg5−/− mice were transduced with mRFP-GFP-LC3-
expressing lentiviruses and cultured for seven days. At day seven cells were treated with Baﬁlomycin A1 for four hours or left untreated and the number of
autophagosomes (mRFP+-GFP+-LC3) and autolysosomes (mRFP+-GFP−-LC3) was determined in the soma b and axon c (three independent experiments
with 15 cells analyzed in each experiment; mean± SEM; two-way ANOVA; Bonferroni post-test). Soma, scale bar: 5 µm. Axon, scale bar: 20 µm. Axon (blow
up), scale bar: 5 µm. d Representative kymographs of autophagosome motility. Cultured motoneurons were transduced with mRFP-GFP-LC3 and the
movement of GFP positive punctae in axons was monitored for 20min. e Proportion of retrogradely, anterogradely or stationary/bidirectionally moving
autophagosomes (mean± SEM; n= 10 cells; two-way ANOVA; Bonferroni post-test). f Number of retrogradely moving autophagosomes per minute
(mean± SEM; n= 10 cells; Studentʼs t-test; one-tailed). g Western blot analysis of LC3 expression in neurosphere-derived cortical neurons from control
and Plekhg5-deﬁcient mice. Cells were treated with 400 nM Baﬁlomycin A1 for 4 h or left untreated. LE low exposure, HE high exposure. h Quantiﬁcation of
LC3 western blots. (Mean± SEM; n= 3; mean± SEM; one-way ANOVA). i Expression of LC3 in spinal cord lysates of three mice per genotype.
j Quantiﬁcation of LC3 Western blots from spinal cord extracts. (mean± SEM; n= 4; mean± SEM; Studentʼs t-test; two-tailed). k NSC34 cells were
transfected with Plekhg5-YFP. Seventy-two hours after transfection, cells were starved for 4 h in HBSS or left untreated. The expression of Plekhg5-YFP
was analyzed by western blot. l Motoneurons were cultured for seven days in motoneuron-media. At day seven cells were cultured for 4 h with different
media each deprived of speciﬁc components. Subsequently, motoneurons were lysed and the expression of endogenous Plekhg5 was analyzed by western
blot. Asterisks label bands that do not change upon nutrient deprivation. Arrowheads point to bands that change upon nutrient deprivation. m NSC34 cells
were transfected with Flag-Plekhg5. Seventy-two hours after transfection, cells were lysed and Flag-Plekhg5 was pulled-down with PI(3)P-coated beads.
Western blot images have been cropped for presentation. Full size images are presented in Supplementary Fig. 7
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defects of Plekhg5-deﬁcient motoneurons (Fig. 8b, e). In contrast,
EGFP-Rab26-QL only moderately enhanced axon growth in wild-
type cells (Fig. 8b, e).
In order to study the effects of constitutive Rab26 on axonal
autophagy, we constructed lentiviral vectors that simultaneously
express RFP-GFP-LC3 and Flag-Rab26-WT or Flag-Rab26-QL
(Fig. 8f, g), respectively. We then quantiﬁed the number of
RFP-GFP-LC3 positive structures in proximal axons and found
that the number of autophagosomes was reduced in Plekhg5-
deﬁcient motoneurons (Fig. 8h, i). This reduction did not
occur in Plekhg5−/− motoneurons expressing constitutive active
Rab26-QL (Fig. 8h, i). In agreement with the data shown in
Fig. 5a–c, the number of autolysosomes remained unaltered.
These data conﬁrm the conclusion that Plekhg5 acts as a GEF for
Rab26 and contributes to autophagosome biogenesis.
Plekhg5 modiﬁes ER-stress in SOD1 G93A motoneurons.
Protein misfolding and endoplasmatic reticulum (ER) stress is a
common disease mechanism in different models of motoneuron
disease31–36. Deﬁciency of global autophagy in neurons results in
an impairment of proteostasis characterized by accumulation
of polyubiquitinated proteins in inclusion bodies8, 9. Plekhg5-
deﬁcient mice did not show any accumulation of
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polyubiquitinated proteins at axon terminals or in motoneuron
cell bodies as shown by immunohistochemical staining
(Supplementary Fig. 6a, b). In addition, we were not able to detect
any differences in the levels of polyubiquitinated proteins by
western blotting (Supplementary Fig. 6c). In contrast, the levels of
Chop and IRE1α were markedly elevated in Plekhg5−/− spinal
cord extracts (Fig. 9c, d). Thus, the unfolded protein response
(UPR) seems to be activated in Plekhg5-deﬁcient mice. We also
tested the expression levels of heat shock protein family members
HSP70 and HSP90 and the ER chaperone Calreticulin by western
blot analyses and found signiﬁcantly decreased expression of all
three chaperones (Fig. 9a, b). Together, these data suggest that
Plekhg5 deﬁciency results in ER-stress without affecting the
turnover of polyubiquitinated proteins.
In order to investigate the relevance of impaired
synaptic vesicle autophagy for motoneuron vulnerability in a
well-characterized model of ALS we depleted Plekhg5 in SOD1
G93A motoneurons in vitro (Fig. 9e–g). We analyzed the effect of
Plekhg5 knockdown with two independent sh-RNA lentiviral
constructs on embryonic SOD1 G93A motoneurons and
investigated ER-stress as a pathogenic mechanism. ER-stress
precedes disease onset in SOD1 transgenic mice37 and modula-
tion of the UPR has been shown to modulate disease onset and
progression in SOD1 transgenic mice38, 39. PERK phosphoryla-
tion, BIP expression and Chop activation were enhanced in a
supra-additive manner in SOD G93A motoneurons with addi-
tional Plekhg5 depletion (Fig. 9e, f). Upon knockdown of
Plekhg5, SOD1 G93A motoneurons also showed a decrease in
survival (Fig. 9g). Interestingly, this effect was observed in
embryonic motoneurons representing a developmental stage long
before disease becomes apparent in vivo. We did not observe any
signiﬁcant changes in the levels of endogenous and transgenic
SOD1 when Plekhg5 is depleted (Fig. 9e, f). Therefore, Plekhg5 is
not involved in the degradation of the mutant SOD1 protein.
These data indicate that both disease mechanisms have additive
effects, cumulating in an elevated load of ER-stress.
Discussion
In summary, our data show that Plekhg5 functions as a GEF for
Rab26, and thus regulates autophagy of synaptic vesicles in axon
terminal of motoneurons. Disruption of this process leads
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to enlarged synaptic vesicles and accumulation of synaptic
proteins resulting in dysfunction of neuromuscular junctions and
motoneuron disease.
Our data suggest that Plekhg5 associates with PIP(3) on
preautophagosomal membranes and regulates the activity of
Rab26 by exchanging GDP to GTP. The observation that Plekhg5
does not regulate Rab5, Rab27b, or Rab33b activity suggests
relative speciﬁcity, but does not exclude the possibility that
Plekhg5 could also regulate the activity of other small GTPases.
However, the observation that constitutively active Rab26 rescues
the phenotype in Plekhg5-deﬁcient motoneurons suggests that
the GEF activity for Rab26 is central for altered autophagy of
synaptic vesicles in motoneurons. In its GTP-bound form Rab26
recruits Atg16l to synaptic vesicles for initiating the delivery of
synaptic vesicles to autophagosomes. Two previously identiﬁed
interaction partners of Plekhg5, Synectin13, and the 14-3-3γ-
protein40, are involved in autophagy regulation41, 42. Both pro-
teins have been described to interact with PI(3)P-kinase, resulting
in the inhibition of autophagy biogenesis. The 14-3-3γ-protein
acts as a scaffold that inhibits the activity of PI(3)P-kinase. In the
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same manner, the 14-3-3γ-protein inhibits the GEF activity of
Plekhg5. Furthermore, protein kinase D mediated phosphoryla-
tion of Ser92 at the N-terminus of Plekhg5 prevents the
interaction between these proteins40. It is tempting to speculate
that phosphorylation of Plekhg5 is the upstream signal to release
14-3-3γ protein from the complex with Plekhg5 and probably
also from PI(3)P-kinase. This might result in initiation of
autophagy and activation of Rab26.
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Fig. 9 Plekhg5 depletion in SOD1 G93A motoneurons results in elevated ER-stress. a Expression of HSP70, HSP90, Calreticulin, and Calnexin in spinal cord
lysates from three animals per genotype. b Quantiﬁcation of western blot shown in a (each data point represents expression levels of one animal;
unpaired t-test; two-tailed). c Expression of IRE1α and Chop1 in spinal cord lysates from three animals per genotype. d Quantiﬁcation of western blot shown
in c (each data point represents expression levels of one animal; unpaired t-test; two-tailed). e SOD1 G93A and non-transgenic motoneurons were depleted
of Plekhg5 and several ER-stress markers were examined after 7 days in culture. f Quantiﬁcation of western blots shown in e (each data point represents
one individual experiment; mean± SEM; unpaired t-test; two-tailed). g Survival of SOD1 G93A motoneurons decreased upon knockdown of Plekhg5 using
two independent sh-RNA constructs (each data point represents the % of motoneuron-survival from one individual embryo. At least 50 motoneurons were
evaluated from one embryo; mean± SEM; two-way ANOVA; Bonferroni post-test). Images have been cropped for presentation. Full size images are
presented in Supplementary Fig. 7
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Deﬁciency of global autophagy in neurons results in an
impairment of proteostasis characterized by accumulation
of polyubiquitinated proteins in inclusion bodies8, 9. Our data
suggest that Plekhg5 deﬁciency does not impair global protein
homeostasis indicating that the defect in Plekhg5−/− mice is
restricted to synaptic vesicles and does not involve misfolding
or aggregation of cytosolic proteins. Thus, Plekhg5−/− mice
represent a model of motoneuron disease without poly-
ubiquitinated protein inclusion in which defective autophagy of
synaptic vesicles stands in the center of the pathophysiology. Such
cases of motoneuron disease without polyubiquitinated inclusions
have been described43 and they seem to correlate with forms of
motoneuron disease with prolonged survival, or with unusual
familial cases of progressive muscular atrophy43.
NMJs might be particularly vulnerable to defects in synaptic
vesicle turnover due to their large presynaptic size and large
number of synaptic vesicles compared to other synapses44. This
idea is supported by the lack of behavioral deﬁcits in Plekhg5-
deﬁcient mice and by the relatively preserved morphology of
synapses in hippocampus, cerebral cortex and cerebellum.
Azzedine et al.19 had previously characterized Plekhg5-deﬁ-
cient mice until 12 months of age, and had not detected moto-
neuron loss at this stage. In our model, symptoms of motoneuron
disease did not start before 12 months (Fig. 1c, e–g). Further-
more, motoneuron loss was not detectable before 12 months of
age, and it progresseed until 24 months (Fig. 1d). Therefore, it is
possible that motoneuron loss would have become apparent in
the model described by Azzedine et al.19 in mice older than
12 months. Furthermore, different strategies for generation of the
null-allele could contribute to the severity of disease. The model
described by Azzedine et al.19 had been generated by insertion of
loxP sites ﬂanking exon 9−13. Excision of this target region
results in a truncated protein lacking the RhoGEF domain but
still containing the PH domain. In our model, the protein lacks
both domains.
Our ﬁndings add to previous reports that neuron-speciﬁc dis-
ruption of autophagy by depletion of Atg5 or Atg7 results in
progressive degeneration of motoneurons8, 9 and that missense
mutations in the autophagy receptors p62/SQSTM1 and opti-
neurin are causative for ALS45, 46. Both proteins are substrates of
Traf family member-associated NF-kappa-B activator (TANK)-
binding kinase 1 (TBK1). Upon phosphorylation, p62/SQSTM1
and optineurin are recruited to mitochondria during PTEN-
induced putative kinase protein 1 (PINK1)/Parkin-mediated
mitophagy47, a mechanism implicated in the pathogenesis of
Parkinson’s disease48. Previous reports on TBK1 mutations in
ALS49, 50 and the recently identiﬁed interaction of the putative
Rab GTPase GEF chromosome 9 open reading frame 72
(C9ORF72) with WD repeat-containing protein 41 (WDR41) and
Smith-Magenis syndrome chromosomal region candidate gene 8
protein (SMCR8)51 support the idea that impaired autophagy
could make major contributions to the pathophysiology of
motoneuron disease. Our study provides a ﬁrst mechanism to
explain how autophagy of synaptic vesicles is regulated in axon
terminals of motoneurons and adds further weight to the
hypothesis that dysregulated autophagy constitutes a major
pathogenic mechanism in motoneuron disease.
Methods
Statistics. Whiskers in box–whisker plots show minima and maxima. Boxes
extend from the ﬁrst to the third quartiles with cross lines at the median. Means are
depicted by plus signs. In dot plots, dots represent individual experiments with
cross lines at the mean ± SEM. When comparing two groups, statistics were
performed using two-tailed Student’s t-tests for unpaired samples assuming
unequal variance. When comparing multiple groups, one-way ANOVA or two-way
ANOVA (grouped analysis) was performed. P values below 0.05 were considered
signiﬁcant (*P< 0.05; **P< 0.01; ***P< 0.001). For multiple comparisons of
individual groups, the Bonferroni post-test was performed. No statistical tests were
used to predetermine sample sizes, but our sample sizes are similar to those
generally employed in the ﬁeld. Normal distribution of data was assumed, but not
formally tested. All statistical analyses were performed using GraphPad Prism 6.00.
Generation of transgenic mice. To generate Plekhg5-deﬁcient mice, embryonic
stem cells (ESCs) with a disruption of one Plekhg5 allele from gene-trap clone
E277F07 (cell line: E14TG2a.4 (ES cells 129P2 (formerly 129/Ola))) were
injected into blastocysts of B6D2F2 (C58bl6/DBA2) mice52 and transferred into
pseudo-pregnant NMRI-foster mothers. Correct insertion site of the gene-trap
cassette was veriﬁed by sequencing. Offspring were genotyped by PCR using
the following primers: a 5′primer located in the intron upstream of the GT-Cassette
(5′ TAAAAGCTGGCAGCCTGAAT 3′), a 3′ primer located in the GT-Cassette
(5′ GCTAGCACAACCCCTCACTC 3′), and a 3′primer located in the intron
downstream of the GT-Cassette (5′ ACCCCAAGGTCTGTCCTCTT 3′).
Mice were backcrossed for at least four generations onto C57Bl/6 background.
Genders within genotypes were grouped, as differences between them were not
statistically signiﬁcant. The age of mice used for individual experiments is indicated
accordingly throughout the results section.
This study was approved by the local veterinary authority (Veterinaeramt der
Stadt Wuerzburg) and Committee on the Ethics of Animal Experiments, i.e.,
Regierung von Unterfranken, Wuerzburg (License number 55.2-2531.01-8/14).
RNA extraction and RT-PCR. Dissected tissues were frozen in liquid nitrogen and
RNA was extracted using standard phenol–chloroform extraction. 1 µg of total
RNA was treated with DNase I (Fermentas) and reverse transcribed with First
Strand cDNA Synthesis Kit (Fermentas). cDNA was diluted 1:5 and 1 µl was
subsequently used as template for RT-PCR reactions.
The following primers were used to validate gene-trap cassette functionality.
According to www.ensemble.org, the murine Plekhg5 locus is can generate four
different protein-coding transcripts. Speciﬁc 5′ primers were used for each
transcript: Isoform 001 and 004: 5′ GAGCTACCCTCCCCAGACTC 3′
(ENSMUSE00000523883), Isoform 003: 5′ CTGCAGAGGAGAAGGGACTG 3′
(ENSMUSE00000594961), Isoform 002: 5′ GGTACCTAGAGGCCCGAAAC 3′
(ENSMUSE00000667027). A common 3′ primer was used for the wild-type-allele:
5′ GGTGCTGTGGAACTTGCTATC 3′ (ENSMUSE00000594961). The following
3′ primer was used to detect expression of the gene-trap-allele: 5′
GGCCTCTTCGCTATTACGC 3′.
Using 3′ primers speciﬁc for exons 6 and exon 9, we conﬁrmed that insertion of
the GT-cassette did not disturb the normal splicing pattern by altering the order of
5′exons or elimination of 5′ exons. The following 3′ primer speciﬁc to exon 6
(ENSMUSE00000594959) was used: 5′ GGCTGGCACAATTTCTGTTT 3′.
The following 3′ primer speciﬁc to exon 9 (ENSMUSE00000594955) was used:
5′ GCAGAGAACAGCTGGAAGGT 3′.
Grip strength measurements. Force measurements were performed on a thin
metal mesh connected to a force meter detecting forces within a range of 0−200 cN.
Mice were suspended and allowed to hold on the grid, and, after they had grasped
the grid using both paws, a force was applied to pull the mice from the grid. The
force required to detach the mice from the grid was recorded, and the mean value
from ﬁve attempts was taken as one data point and considered as the grip strength.
Nissl staining and quantiﬁcation of spinal motoneurons. Mice were deeply
anaesthetized and trans-cardially perfused with 4% PFA. 12.5 µm parafﬁn
serial sections of the spinal cord were produced for Nissl staining, as described
previously53. Cresyl violet intensively stains acidic structures within cells, and
renders the nucleolus and the rough endoplasmic reticulum visible. Only
motoneurons with a clearly distinguishable nucleolus, that had Nissl-stained
rough endoplasmic reticulum-like structure in the cell body were counted in
every tenth section of the lumbar spinal cord (L1–L8). Raw counts were
corrected for double counting of split nucleoli as described53.
Succinate dehydrogenase enzyme activity. Succinate dehydrogenase (SDH)
stain was used to distinguish between oxidative and glycolytic ﬁbers on 10 µm thick
cryosections of tibialis anterior leg muscles. SDH staining was performed on fresh,
untreated 10 µm cryosections that were incubated for 5 min in the dark at room
temperature in standard SDH-substrate solution (0.2 M Na-succinat, 10 mM KCN,
10 mM nitro-blue tetrazolium, 2 mM phenazin methosulfate in phosphate buffer at
pH 7.2). Reaction was stopped with 3,7% buffered formaldehyde. Stained sections
were photographed under identical conditions.
Immunohistochemical staining of neuromuscular junctions. Staining of NMJs
was carried out as previously described54. Brieﬂy, mice were deeply anaesthetized
and trans-cardially perfused with 4% paraformaldehyde (PFA). Subsequently, the
muscles were dissected and post-ﬁxed in 4% PFA for at least 2 hours. The tissue
was washed in PBS-T (0.1% Tween-20) for 20 min at room temperature (RT) and
incubated with ω-Bungarotoxin-Alexa-488 (Invitrogen) for 25 min at RT. The
tissue was then incubated overnight at 4 °C with a blocking solution (2% BSA, 0.1%
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Tween-20 and 10% donkey serum), followed by incubation with the primary
antibodies for 3 days at 4 °C. After washing with PBS at pH 7.4 (PAA Laboratories)
thrice for 15 min, the appropriate secondary antibodies were applied for 1 h at RT.
The tissue was washed again as above, and embedded in Aqua Polymount
(Polysciences). The following primary antibodies were used: anti-NF-H (1:5000;
Millipore, AB5539), anti-Synaptophysin-1 (1:500; Synaptic Systems, 101 004).
Alexa-647 and Alexa-546-conjugated secondary antibodies were from Jackson
Immuno-Research Laboratories.
Immunoﬂuorescence staining of free-ﬂoating sections. Mice were deeply
anaesthetized and trans-cardially perfused with 4% PFA. After removal of the spinal
cord, spinal cord was post-ﬁxed in 4% PFA overnight and subsequently incubated in
30% sucrose at 4 °C overnight. Thirty-ﬁve micrometers of thick free-ﬂoating
sections were cut on a Leica 9000 s sliding microtome as described previously62 and
collected in 0.1M phosphate buffer (PB) pH 7.4. After incubation of the sections for
1 h with 4% normal goat or donkey serum and 0.3% Triton X-100 for blocking of
nonspeciﬁc binding at room temperature, sections were incubated overnight at 4 °C
with primary antibodies in blocking solution. After three times 10min washing in
0.25% Triton X-100 in PB at room temperature, sections were incubated in with
ﬂuorescently labeled secondary antibodies, washed again and ﬁnally mounted with
Mowiol/DABCO. The following primary antibodies were used: anti-NeuN (1:1000;
Millipore, MAB377, clone A60), ChAT (1:1000; Millipore, MAB144P), anti-
Ubiquitin (1:500; DAKO, Z0458), anti-Synaptophysin-1 (1:500; Synaptic
Systems, 101 004). Alexa-647-, Alexa-488-, and Alexa-546-conjugated secondary
antibodies were from Jackson Immuno-Research Laboratories. For visualization of
F-actin Alexa Flour 532 conjugated Phalloidin (Invitrogen) was used.
Electron microscopy. Mice were anesthetized and trans-cardially perfused
according to local institutional guidelines in 3 steps, slightly modiﬁed according to
Forssmann et al.55 with 3% paraformaldehyde, 3% glutaraldehyde, 0.5% picric acid
in 0.1 M sodium phosphate buffer, pH 7.2 for 10 min. Dissected organs were ﬁxed
in the same solution for additional 1−2 h at 4 °C, post-ﬁxed in buffered 2% osmium
tetroxide (2.5 h, 4 °C), and embedded in Araldite.
To analyze the ultrastructure of NMJs, animals were trans-cardially perfused
under deep anesthesia for 40 s with heparin/procaine followed by 2% formaldehyde
and 4% glutaraldehyde in 0.1 M cacodylate buffer with 2 mM MgCl2 and 3 mM
CaCl2 for 10 min. Dissected organs were further ﬁxed for 2−4 h at 4 °C and
post-ﬁxed with 2% OsO4 and 0.15% potassium hexacyanoferrate(III) to enhance
visibility of the extracellular matrix.
For identiﬁcation of target regions by optical microscopy, 1.5 µm-thick sections
were stained with Richardson’s blue (1% w/v methylene blue, 1% w/v Azur II) for
3 min at 80 °C. 60−80 nm sections (stained for 40 min in uranyl acetate and 8 min
in lead citrate) were used for electron microscopy (Zeiss EM 109).
Primary motoneuron culture. Murine embryonic spinal motoneurons were iso-
lated and cultured as described56. Brieﬂy, after dissection of the ventrolateral part
of E12.5 embryos, spinal cord tissues were incubated for 15 min in 0.05% trypsin in
Hank’s balanced salt solution. Cells were triturated and incubated in Neurobasal
medium (Invitrogen), supplemented with 1× Glutamax (Invitrogen) on Nunclon
plates (Nunc) pre-coated with antibodies against the p75 NGF receptor (MLR2,
kind gift of Robert Rush, Flinders University, Adelaide, Australia) for 45 min.
Plates were washed with Neurobasal medium, and the remaining motoneurons
were recovered from the plate with depolarization solution (0.8% NaCl, 35 mM
KCl and 2 mM CaCl2) and collected in full medium (2% horse serum, 1× B27 in
Neurobasal medium with 1× Glutamax). After counting, cell number was adjusted
to 1000 in 100 µl, and 1000 cells were plated on four-well dishes (Greiner, Cellstar)
pre-coated with poly-ornithine/laminin (Invitrogen). Cells were cultured in the
presence of the neurotrophic factor BDNF. For survival assays, cells were counted
4 h after plating to ﬁnd the total number of plated cells. Cells were counted again
after 5 and after 7 days in vitro (DIV).
For lentiviral transduction, motoneurons were incubated with viral particles for
10 min at RT directly before plating.
Culture of neurospheres. The forebrain was dissected from 11.5 to 12.5-day- old
mouse embryos and transferred to 100 μl HBSS. After treatment with trypsin
(Gibco; 0.05%, 15 min), cell suspensions were generated by trituration. Trypsin was
inactivated with egg yolk sack trypsin inhibitor (Sigma; 0.05%), and cells were
plated on 75 ml ﬂasks (Greiner) in 5 ml Neurobasal medium (Invitrogen)
containing Glutamax (1:100), B27 supplement (Invitrogen), basic ﬁbroblast growth
factor (bFGF), and epidermal growth factor (EGF) (Peprotech), each at a ﬁnal
concentration of 10 ng/ml. Cells were passaged at least once before being used in
the ﬁrst experiment. For differentiation, neurospheres were dissociated using 0.05%
trypsin and plated on Poly-L-ornithine-coated dishes at a density of 20,000 cells per
cm2. One day after plating, cells were transferred to an EGF and bFGF-depleted
medium, and cultured for the indicated time intervals.
Immunocytochemistry. For immunocytochemistry, cells grown on glass coverslips
were ﬁxed with buffered PFA for 20 min at RT, washed three times with PBS for 15
min, and blocked for 30 min with blocking buffer containing 10% donkey serum
and 0.3% Triton X-100 in TBST (TBS-Tween). After three washes with TBST for
5 min at room temperature, cells were incubated with primary antibodies overnight
at 4 °C, followed by three washes in TBST at RT for 15 min, and then incubated
with the appropriate ﬂuorophore-conjugated secondary antibodies for 1 h.
Subsequently, cells were washes three times with TBST for 15 min. The coverslips
were mounted on glass slides with Aqua Polymount. Cells were imaged using an
Olympus Fluoview 1000i confocal microscope. The following primary antibodies
were used: anti-phospho-Tau (Ser199/202) (1:500; Sigma-Aldrich, T6819),
anti-Rab26 (1:500; Synaptic Systems, 269 011, clone 163E12), anti-Synaptophysin-1
(1:500; Synaptic Systems, 101 004). Alexa-647-, Alexa-488- and Alexa-546-
conjugated secondary antibodies were purchased from Jackson Immuno-Research
Laboratories. For visualization of F-actin Alexa Flour 532 conjugated Phalloidin-
(Invitrogen) was used.
Plasmid construction. FUW-RFP-GFP-LC3 was generated by digestion of the
FUWG plasmid by Xba and EcoRI, and the resulting 10 kB fragment was puriﬁed
by gel extraction. pmRFP-GFP-rLC357 was digested by NheI and EcoRI, and the
resulting insert was puriﬁed by gel extraction and cloned into the FUW backbone
by ligation. The XbaI site was destroyed during cloning.
For generation of FUW-EGFP-Rab26-WT and FUW-EGFP-Rab26-QL15,
pEGFP-Rab26-WT, and pEGFP-Rab26-WT were digested by BamHI and NheI
and the resulting fragments puriﬁed by gel extraction. Subsequently, both inserts
were ligated into the BamHI and XbaI sites of FUWG.
For generation of FUW-mRFP-GFP-LC3-CMV-Flag-Rab26, pCMV-Tag2a-
Flag-Rab26 was digested by SalI and the resulting CMV-Flag-Rab26 fragment was
puriﬁed, blunted and phosphorylated. FUW-RFP-GFP-LC3 was digested by EcoRI
and blunted. Subsequently, both fragments were ligated.
To generate Plekhg5 knockdown constructs, different short hairpin (sh)-
sequences were synthesized as sense and antisense oligos, and cloned into the
BamHI and EcoRI restriction sites of pSIH-H1-eGFP. The following sequences
were validated for their ability to knockdown Plekhg5: sh-A: 5′
TCAAGTCGGTGCTAAGGAA 3′; sh-B: 5′ ATAGCAAGATGGACGTGTA 3′;
sh-C: 5′ GGACACTATTTACAACGCA 3′; sh-D: 5′ GGACGAATCTT
CTCTCAGT 3′; sh-E: 5′ CGCAAGAACATGTCTGAAT 3′. Sh-D was used in the
experiments, if not indicated otherwise.
The DH-PH domain of Pleghg5 was generated by amplifying the coding DNA
from cDNA of human Plekhg5 (BC042606) as a template using following primers
(uppercase letters indicate gene-speciﬁc nucleotides): 5′
atctggttccgcgtggatccGATGGGCATGAGAAGCTG 3′, 5′
tcacgatgcggccgctcgagTCACTGTGCACGCAGCTG 3′. The PCR product was
cloned into the pGEX-4T vector using the Gibson assembly kit (New England
Biolabs) according to the manufacturerʼs protocol.
GST-hRab26WT and GST-mRab5WT were cloned into pGEX-2T as described.
Lentivirus production. Lentivirus was produced by co-transfecting HEK 293T cells
with the indicated expression and packaging plasmids using Lipofectamine 2000
(Invitrogen). The medium was replaced 24 h after transfection and collected 24 h
later. Subsequently, the virus was concentrated by ultracentrifugation.
Western blotting. Equal amounts of protein were separated by SDS-PAGE, and
transferred to PVDF or nitrocellulose membranes (Pall). Membranes were blocked
in TBST with 5% milk powder for 1 h at RT, probed with primary antibodies
overnight at 4 °C, and incubated with horseradish peroxidase-conjugated second-
ary antibodies for 1 h at RT. The following primary antibodies were used: anti-LC3
(1:2000; Novus Biologicals, NB100-2220), anti-Calreticulin (1:8000; Thermo Sci-
entiﬁc, PA1-902A), anti-Calnexin (1:8000; Enzo, ADI-SPA-860), anti-HSP90
(1:4000; Enzo, ADI-SPA-830-D, clone AC88), anti-HSP70 (1:2000; Cell Signaling,
4872 T), anti-BiP (1:2000; Cell Signaling, 3177P, clone C50B12), anti-CHOP
(1:1000; Cell Signaling, 2895, clone L63F7), anti-PERK (1:1000; Sigma-Aldrich,
P0074), anti-phospho-Perk (Thr980) (1:1000; Cell Signaling, 3179, clone 16F8),
anti-Tuj1 (1:4000; Neuromics, MO15013), anti-Flag (1:10,000, Sigma-Aldrich,
F7425), anti-Actin (1:8000; Millipore, MAB1501R), anti-Gapdh (1:8000; Calbio-
chem, CB1001, clone 6C5), anti-IRE1α (1:1000; Cell Signaling, 3294), anti-
Ubiquitin (1:1000, Enzo, BML-PW0930, clone P4D1), anti-Rab26 (1:1000; Cell
Signaling 269 011, clone 163E12), anti-Synaptophysin-1 (1:2000; Synaptic Systems,
101 004), anti-Synapsin-1 (1:4000; Synaptic Systems, 106 103), anti-Syntaxin 1A
(1:1000; Synaptic Systems, 110 111, clone 78.3), anti-Synaptotagmin-1 (1:1000;
Synaptic Systems, 105 011,clone 41.1), anti-Synaptobrevin-2 (1:1000; Synaptic
Systems, 104 211, clone 69.1), anti-Snap 25 (1:1000, Synaptic Systems, 111 011,
clone 71.1) Appropriate peroxidase-conjugated secondary antibodies were from
Jackson Immuno-Research Laboratories.
Culture and transfection of NSC34 cells. NSC34 cells were cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM, Gibco) containing 10% FCS,
1× Glutamax and 1× Penicillin/Streptomycin and transfected with Turbofect
(Life Technologies). For pull-down experiments, 1 day prior to transfection
2 × 106 cells were plated on 6 cm dishes and transfected using 8 µg plasmid and
24 µl Turbofect. For starvation experiments 1 × 106 cells were plated on six-well
plates one day before transfection. The next day, cells were transfected using
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4 µg plasmid and 12 µl Turbofect. Transfections were carried out according to the
manufactures instructions. All subsequent assays were performed 72 h after
transfection.
Lipid beads pull-down assay. Lipid beads pull-down assays were performed as
described58, with minor modiﬁcations. NSC34 cells transiently expressing Plekhg5-
Flag were suspended in lipid-binding buffer (20 mM Tris-HCl, 150 mM NaCl, and
1 mM EDTA, pH 7.5). The cells were extruded 10 times through a G25 syringe
needle and sonicated on ice. After removal of insoluble debris by high-speed
centrifugation at 13,000×g for 1 h at 4 °C, a 50 µl slurry of PI(3)P-conjugated or
unconjugated beads (Echelon Bioscience) was added to the tube and rotated for 2 h
at 4 °C. After washing the rotating beads ﬁve times for 20 min at 4 °C with lipid-
wash buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 0.25% NP-40), bound proteins
were eluted by boiling in 2× Laemmli buffer.
Metabolic labeling, IP and thin layer chromatography. 106 cells from dissociated
neurospheres were plated on PORN-coated 10 cm dishes. A day after plating, the
growth medium was replaced by bFGF and EGF-depleted medium. Three days
after plating, cells were transduced with FUW-Rab26-WT and cultured for addi-
tional 96 h. Thirty minutes before 32P labeling, cells were switched to phosphate-
free medium. Subsequently, cells were labeled for 4 h in phosphate-free medium
containing 1 mCi32Pi in a volume of 6 ml phosphate-free medium. After labeling,
cells were washed once with 5 ml ice-cold PBS and placed in 500 µl lysis buffer
(50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% Triton X-100, 0.5%
CHAPS supplemented with protease inhibitors). Plates were kept on ice for 10 min,
and then centrifuged for 3 min at maximum speed. A lysate aliquot was retained
for Western blotting to test loading similarity of the samples.
Supernatants were transferred to microfuge tubes containing 30 µl GFP
antibody conjugated to agarose (clone RQ2, MBL) and incubated for 2 h at 4 °C
while mixing. Beads were then washed ﬁve times in ice-cold lysis buffer and
nucleotides bound to the GTPase were eluted in 20 µl elution buffer (2 mM EDTA,
1 mM GTP, 0.2% SDS, 5 mM DTT) at 65 °C for 5 min. Ten microlitre eluate was
spotted on 20 × 20 cm polyethylenimine (PEI) cellulose plates (Macherey-Nagel)
and separated in a chromatography chamber saturated with 0.75M KH2PO4 (pH
3.4). Chromatography chambers were prepared one day in advance by ﬁlling the
bottom with 50 ml potassium phosphate solution. GDP and GTP were separated by
placing the dry TLC sheet upright in a sealed chamber until the solvent has
ascended to 70% of its length. After drying, TLC plates were exposed to an X-ray
ﬁlm for 3–5 days.
Protein expression and puriﬁcation. The GST-tagged DH-PH domain (amino
acids 362–748) of human Plekhg5 protein, GST-tagged human Rab26-WT and
GST-tagged mouse Rab5-WT were expressed in BL21 (DE3) E. Coli. One litre of
Terriﬁc Broth supplemented with salt and 100 mg/ml of ampicillin was inoculated
with 200 ml of an overnight (o.n.) culture for 3 h at 37 °C to an OD of 0.8.
Subsequently, expression was induced by adding 0.2 mM IPTG and bacteria were
incubated o.n. at 22 °C. Bacteria were pelleted at 4000 r.p.m. for 15 min. Pellets
were washed in 1× PBS, centrifuged again as above, and resuspended in Plekhg5
(20 mM HEPES pH 7.4, 500 mM NaCl, 1 mM DTT, 5 mM EDTA and 10% gly-
cerol), or Rab26/Rab5 (20 mM Tris pH 7.4, 500 mM NaCl, 5 mM MgCl2, 100 µM
GDP and 5 mM DTT) protein buffer. Cell suspensions were lysed with lysozym
(Roth), supplemented with inhibitor cocktail (Roche), 1 mg/l DNase (Applichem),
and 1% Triton X-100. Lysates were sonicated (Branson Soniﬁer 450) four times for
30 s. In between, lysates were and kept on ice for 30 s. Lysates were pre-cleared by
centrifugation at 13,000 r.p.m. for 45 min. Supernatants were ﬁltered through a
0.45 µm (Whatman) ﬁlter, and rotated with glutathione conjugated to sepharose
(Amersham Bioscience) for 2 h at 4 °C. After collecting the ﬂow-through, the
bound fraction was washed with 1 l of protein buffer supplemented with 1 mM
ATP and 0.1% Triton X-100 for the DH-PH domain of PleghG5, 1% Triton X-100
for Rab26, or no additive for Rab5. Subsequently, Rab5 and Rab26 samples were
digested in protein buffer supplemented with 150 mM NaCl and 5 mg/ml thrombin
o.n. at 4 °C. The Rab5 sample was loaded on a Superdex 75 16/60 column (GE
healthcare). The GST-DH/PH domain was eluted by 30 mM free and reduced
glutathione. The beads were incubated four times with 10 ml of elution buffer for
10 min. Fraction were examined by
SDS-PAGE. The protein-containing fractions were combined and dialyzed in
protein buffer containing 150 mM NaCl and 0,1% Triton X-100 o.n. Puriﬁed
proteins were snap frozen and stored at −80 °C.
For Rab27B and Rab33B the beads were washed with 500 ml wash buffer
containing 20 mM HEPES pH 7.4, 500 mM NaCl, 5 mMMgCl2 and 50 mM HEPES
pH 7.5, 200 mM NaCl, 5 mM MgCl2, respectively.
The proteins were eluted in their respective wash buffer supplemented with
400mM imidazole 4−5 times with 7ml buffer each elution fraction. Then the proteins
were dialyzed with wash buffer containing reduced salt concentration of 150mM
NaCl. Rab33B was dialyzed in wash buffer containing 30mM HEPES. All the puriﬁed
proteins were snap frozen and stored at −80 °C for downstream experiments such as
GEF assay.
Measurement of rapid kinetics. Nucleotide binding to Rab GTPases was
analyzed by stopped ﬂow instrument (SX-20 MV, Applied Photophysics) using
Mant-GppNHp (Jena Bioscience GmbH). An aliquot of 100 nM Mant-GppNHp,
either in the presence or absence of 10 µm Plekhg5, was rapidly mixed with 1 µm
Rab GTPase in 10 mM MgCl2, 20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM DTT
and 5% glycerol. Mant-GppNHp was excited at 366 nm and ﬂuorescence emission
was monitored using a passing cut-off ﬁlter (KV395, Schott).
Electrophysiological analyses. For the electrophysiological tests six wild-type
(3 female, 3 male) and six knockout (2 female, 4 male) animals were used.
Electrophysiological experiments were carried out in accordance with the
internationally accepted principles in the care and use of experimental animals,
approved by the local Institutional Animal Care and Research Advisory Committee
and permitted by the local government (Lower Saxony, Germany; AZ 13/1070).
Mice were housed under controlled conditions in the Central Animal Facility of
Hannover Medical School for nearly one week before measurements. Animals were
anaesthetized by isoﬂurane (1.5–2% with pure oxygen (1 l/min); Baxter AG,
Unterschleißheim, Germany). Prior to the electrophysiological measurements
Carprofen (0.01 ml/100 g; 5 mg/kg; Rimadyl, Pﬁzer GmbH, Karlsruhe, Germany)
was given subcutaneously for analgesia, and dexpanthenol eye ointment
(Bepanthen Augen-und Nasensalbe, Bayer Vital GmbH, Leverkusen, Germany)
was applied to the eyes to prevent corneal dehydration. During measurements,
body temperature of the animals, monitored and recorded rectally, was maintained
between 33 and 37 °C by using a thermostat heating plate (direct current). Portable
EMG equipment (Natus Keypoint Focus, Natus Europe GmbH, Planegg, Germany)
along with the Keypoint.net (version 2.32) computer program was used. For
nerve conduction studies, the sciatic nerve of ~ 24-month-old animals was
stimulated percutaneously by single pulses of 0.1 ms and 1 Hz delivered through
a pair of needle electrodes (Spes Medica disposable monopolar needle electrode,
13 mm × 33 G, GVB geliMED KG, Bad Segeberg, Germany) placed proximally at
the sciatic notch and distally at the popliteal fossa. The distance between both
stimulation electrodes was measured. Reference electrodes were inserted
subcutaneously a few millimeters apart from the stimulation electrodes. The
maximal compound muscle action potential (CMAP) was recorded using needle
electrodes (same as for stimulation) at the gastrocnemius, anterior tibial or
plantaris muscles. The reference electrode for all three muscles was placed in the
fourth toe. The ground electrode was inserted subcutaneously rostral to the
stimulation electrodes. Amplitude (baseline-peak, mean proximal/ distal)
and latency (time from stimulus to the onset of ﬁrst negative deﬂection, mean
proximal/ distal) were measured. Nerve conduction velocity (NCV) was calculated
via the latency differences of the proximal and distal stimulation and the
stimulation distance (mean NCV per muscle gastrocnemius/ tibialis). Motor unit
number estimation (MUNE) was performed subsequently to the nerve conduction
study, based on the description in Arnold et al.59. At least ten single motor unit
potentials (SMUPs; baseline-peak amplitude) were obtained by incremental
stimulation technique (1 Hz, 0.1 ms, 0.02 mA increase). Only increases over 25 μV
in the amplitude were recorded trying to minimize the inﬂuence of alternation. The
incremental values of the SMUPs were averaged in order to determine the size of
the mean SMUP. In the end, the estimated number of motor units within the
tibialis and gastrocnemius muscle was calculated by dividing the respective mean
SMUP into the maximum CMAP amplitude.
Mechanical sensitivity. To determine mechanical paw withdrawal thresholds, we
used the von Frey test based on the up-and-down-method of Chaplan et al.60.
Experimental mice were placed on a wire mesh in individual acrylic-glas cages and
the plantar surface of the hind paws was alternately touched with a calibrated von
Frey ﬁlament applying mild pressure leading to a slight bending of the ﬁlament; the
experiment was started at 0.69 g. Upon hind paw withdrawal the next thinner von
Frey ﬁlament was used. If the hind paw was not withdrawn, the next thicker von
Frey ﬁlament was used. Each hind paw was assessed three consecutive times and
the 50% withdrawal threshold (i.e. force of the von Frey hair to which an animal
reacts in 50% of the administrations) was calculated.
Heat sensitivity. To determine paw withdrawal latencies upon heat stimulation we
applied a standard algometer (Ugo Basile, Gemonio, Italy) based on the method of
Hargreaves et al.61. Experimental mice were placed on a glass surface in individual
plexiglas cages and a radiant heat source (25 IR) was placed under one hind paw
each. Time until paw withdrawal was recorded automatically. Heat application was
limited to 16 s to avoid tissue damage. Each hind paw was tested three times
consecutively.
Behavior. Plekhg5-deﬁcient (n= 10) and control mice (n = 11), at age of
12−14 months with no symptoms of motoneuron disease were used for behavioral
analysis. Genders within genotypes were grouped, as differences between
them were not statistically signiﬁcant. Mice were housed individually under a 12 h
light/dark cycle (6:00 a.m.−6:00 p.m.) with ad libitum access to food and water. The
cages (Tecniplast, 1264 C Eurostandard Typ II, 267 × 207 × 140 mm) were kept in a
Scantainer (Scanbur Ltd. Denmark) assuring stable conditions through a constant
airﬂow and maintaining a temperature of about 21 °C and air humidity of about
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55%. Experimental procedures took place during the light phase of the cycle
between 8:00 a.m. and 5:00 p.m. Mice were transported in their home cage to a
separate room and allowed to calm down for half an hour. Then mice were taken
individually in their home cages to the experimental room for experiments. The
experimenter was unaware of the genotype to keep experiments unbiased.
For the Open Field test, mice were placed in the middle of an open ﬁeld arena
(48 × 48 cm, height 50 cm, evenly illuminated to ~ 40 lux) and ﬁlmed for 10 min
with a webcam-based system (Logitech). Movements of the mice were tracked with
VideoMot2 (TSE, Germany) and the following parameters were analyzed: time
spent in center, number of entries into center. The area was cleaned thoroughly
with water after each trial.
The Object Recognition experiments took place in the open ﬁeld arena. For the
object recognition task two kinds of objects were used: a cell culture ﬂask and a
tower of about the same size built of differently colored Lego bricks. The objects
were placed in diagonally opposing corners of the arena with 12 cm distance to
from both sides of the wall. On day 1 half of the animals were presented with two
cell culture ﬂasks, the other half with two Lego towers. Mice were placed in the
middle of the arena and allowed to explore the arena and the objects for 10 min.
On day 2 one of the objects was replaced by a novel object (either cell culture ﬂask
or Lego tower) at either position 1 or 2 in a pseudo-randomized manner to avoid
position bias. Each mouse was therefore confronted with a familiar and a novel
object and was allowed to explore freely for 10 min. Mice were automatically
tracked (see above). We scored exploratory behavior toward objects manually
whenever the mouse sniffed the object or touched the object while looking at it.
After each trial, the arena and the objects were cleaned with water.
Fear conditioning was performed in a fear conditioning apparatus (mouse
multi-conditioning system, 256060 series, TSE, Germany). Fear conditioning took
place in context A, which consisted of a square arena with two blackened sides
placed on a metal grid. Context B, a round arena, which was placed on a black
plastic ground, served as new context. To support context discrimination, mild
olfactory cues were introduced into the arenas by wiping them with tissue paper
moistened with 70% ethanol for context A and 1% acetic acid for context B. The
conditioning consisted of two phases. On day 1 (fear acquisition), mice were
exposed to context A for 180 s before a tone (CS, 80 dB, 5000 Hz) was presented for
10 s and co-terminated with an electric foot shock of 0.7 mA for 1 s (US). The CS
and the US were presented three times with an inter-stimulus-interval (ISI) of 20 s.
After the last presentation, mice stayed in context A for 150 s before being returned
to the home cage. On day 2, mice were placed in context B to test for context
discrimination. For fear retrieval, after 60 s of free exploration the CS was presented
without the US for 12 times with an ISI of 20 s. After another 60 s mice were
returned to their home cage. Mice were video tracked and movement was recorded
by a light beam system. Freezing behavior, deﬁned as immobility except for
respiration movements, was analyzed with a software-based system (TSE MCS
FCS) and a freezing threshold of 2 s. After each trial, the context was cleaned with
70% ethanol or 1% acetic acid, respectively.
To account for statistical differences between genotypes and conditions
depending on the experiment, two-way ANOVAs with post hoc Sidak’s multiple
comparison test or unpaired t-tests were performed. Analyses were performed with
GraphPad Prism 6 and are represented as± SEM. Results were considered
statistically signiﬁcant at P< 0.05.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles or
from the corresponding author on reasonable request.
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